XNASBIOX
Market cap397mUSD
Dec 23, Last price
6.33USD
1D
2.26%
1Q
-22.04%
IPO
-34.34%
Name
Bioceres Crop Solutions Corp
Chart & Performance
P/E
122.67
P/S
0.86
EPS
0.05
Div Yield, %
0.00%
Shrs. gr., 5y
15.81%
Rev. gr., 5y
23.73%
Revenues
465m
+10.82%
Net income
3m
-82.73%
CFO
42m
+1,511.43%
Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Uruguay, France, South Africa, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2015‑12 | |
| Income | |||||||||
Revenues | 464,829 10.82% | 419,446 27.70% | 328,456 58.91% | ||||||
Cost of revenue | 394,689 | 341,481 | 267,987 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | 70,139 | 77,966 | 60,469 | ||||||
NOPBT Margin | 15.09% | 18.59% | 18.41% | ||||||
Operating Taxes | 3,779 | (1,069) | 17,973 | ||||||
Tax Rate | 5.39% | 29.72% | |||||||
NOPAT | 66,361 | 79,034 | 42,496 | ||||||
Net income | 3,243 -82.73% | 18,780 -360.85% | (7,200) 4.80% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | (734) | (2,997) | |||||||
BB yield | 0.10% | 0.36% | |||||||
| Debt | |||||||||
Debt current | 139,870 | 111,498 | 72,714 | ||||||
Long-term debt | 142,360 | 159,804 | 108,826 | ||||||
Deferred revenue | 1,925 | 2,058 | 1,321 | ||||||
Other long-term liabilities | 4,057 | 5,093 | 9,854 | ||||||
Net debt | 185,640 | 171,509 | 103,755 | ||||||
| Cash flow | |||||||||
Cash from operating activities | 41,717 | 2,589 | (17,515) | ||||||
CAPEX | (9,790) | (22,563) | (8,998) | ||||||
Cash from investing activities | (28,728) | (25,726) | 2,903 | ||||||
Cash from financing activities | (10,056) | 32,954 | 14,824 | ||||||
FCF | 42,559 | 14,520 | (5,210) | ||||||
| Balance | |||||||||
Cash | 56,169 | 60,052 | 38,611 | ||||||
Long term investments | 40,421 | 39,742 | 39,174 | ||||||
Excess cash | 73,348 | 78,821 | 61,362 | ||||||
Stockholders' equity | 54,517 | 18,871 | (17) | ||||||
Invested Capital | 571,975 | 576,188 | 330,476 | ||||||
ROIC | 11.56% | 17.43% | 13.51% | ||||||
ROCE | 10.61% | 12.36% | 16.82% | ||||||
| EV | |||||||||
Common stock shares outstanding | 63,485 | 63,186 | 42,302 | ||||||
Price | 11.21 -16.09% | 13.36 -2.55% | 13.71 -2.42% | ||||||
Market cap | 711,672 -15.69% | 844,158 45.55% | 579,965 5.25% | ||||||
EV | 933,392 | 1,047,313 | 714,404 | ||||||
EBITDA | 91,435 | 97,356 | 69,656 | ||||||
EV/EBITDA | 10.21 | 10.76 | 10.26 | ||||||
Interest | 26,872 | 21,230 | 14,953 | ||||||
Interest/NOPBT | 38.31% | 27.23% | 24.73% | ||||||